[1] A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection

[2] Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease

[3] Variation in severity of respiratory syncytial virus infections with subtype

[4] Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection

[5] Role of peripheral chemoreceptors and central chemosensitivity in the regulation of respiration and circulation

[6] Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice

[7] [Regional blood filling in hypoxic hypoxia]

[8] In vitro and in vivo sensitivity of a non-mouse-adapted influenza A (Beijing) virus infection to amantadine and ribavirin

[9] Early goal-directed therapy in the treatment of severe sepsis and septic shock